Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Newman, L. A.
Right arrow Articles by Singletary, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Newman, L. A.
Right arrow Articles by Singletary, S. E.

Annals of Surgical Oncology, Vol 5, Issue 7 620-626, Copyright © 1998 by Society of Surgical Oncology


ARTICLES

Presentation, treatment, and outcome of local recurrence afterskin-sparing mastectomy and immediate breast reconstruction

L. A. Newman, H. M. Kuerer, K. K. Hunt, S. S. Kroll, F. C. Ames, M. I. Ross, B. W. Feig and S. E. Singletary
Department of Surgical Oncology, The University of Texas M.D. Anderson Center, Houston 77030, USA.

BACKGROUND: The local recurrence (LR) rate with skin-sparing mastectomy (SSM) and immediate breast reconstruction (IBR) has been reported as comparable to the LR rate after conventional mastectomy. However, limited data are available on the prognostic significance and management of LR following SSM. METHODS: A prospective database maintained at the University of Texas M. D. Anderson Cancer Center identified 437 SSMs performed for 372 invasive T1/T2 breast cancers between 1986 and 1993. RESULTS: Twenty-three LRs were identified, with a LR rate of 6.2% (23/372). Twenty-two of these (96%) presented as palpable skin-flap masses. The median time to recurrence was 25 months (range, 3 to 98 months). Fourteen patients were treated with a combination of surgery and systemic therapy. Resection of the reconstructed breast was performed in only three patients. Complete local control of the recurrent disease was achieved in 17 patients (74%). Nine patients (39%) developed distant metastatic disease. At a median follow-up of 26 months, 14 of 23 patients (61%) are alive without evidence of disease, and 7 (30%) have died from breast cancer. CONCLUSIONS: Because LR rate with SSM is low and likelihood of local control and survival is high, SSM and IBR is an acceptable treatment option for early stage breast cancer.


This article has been cited by other articles:


Home page
RadiologyHome page
J. M. Lee, D. Georgian-Smith, G. S. Gazelle, E. F. Halpern, E. A. Rafferty, R. H. Moore, E. D. Yeh, H. A. D'Alessandro, R. A. Hitt, and D. B. Kopans
Detecting Nonpalpable Recurrent Breast Cancer: The Role of Routine Mammographic Screening of Transverse Rectus Abdominis Myocutaneous Flap Reconstructions
Radiology, August 1, 2008; 248(2): 398 - 405.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
D. Cao, T. N. Tsangaris, N. Kouprina, L. S.-F. Wu, C. M. Balch, R. Vang, and P. Argani
The Superficial Margin of the Skin-Sparing Mastectomy for Breast Carcinoma: Factors Predicting Involvement and Efficacy of Additional Margin Sampling
Ann. Surg. Oncol., May 1, 2008; 15(5): 1330 - 1340.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
A. J. Stolier and J. Wang
Terminal Duct Lobular Units are Scarce in the Nipple: Implications for Prophylactic Nipple-Sparing Mastectomy: Terminal Duct Lobular Units in the Nipple
Ann. Surg. Oncol., February 1, 2008; 15(2): 438 - 442.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
R. Z. Torresan, C. C. dos Santos, H. Okamura, and M. Alvarenga
Evaluation of Residual Glandular Tissue After Skin-Sparing Mastectomies
Ann. Surg. Oncol., December 1, 2005; 12(12): 1037 - 1044.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
R. D. Foster, S. L. Hansen, L. J. Esserman, E. S. Hwang, C. Ewing, K. Lane, and J. P. Anthony
Safety of Immediate Transverse Rectus Abdominis Myocutaneous Breast Reconstruction for Patients With Locally Advanced Disease
Arch Surg, February 1, 2005; 140(2): 196 - 200.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. E. Singletary and G. L. Robb
Oncologic Safety of Skin-Sparing Mastectomy
Ann. Surg. Oncol., March 1, 2003; 10(2): 95 - 97.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
C. M. Ho, C. K. L. Mak, Y. Lau, W. Y. Cheung, M. C. M. Chan, and W. K. Hung
Skin Involvement in Invasive Breast Carcinoma: Safety of Skin-Sparing Mastectomy
Ann. Surg. Oncol., March 1, 2003; 10(2): 102 - 107.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
G. W. Carlson, T. M. Styblo, R. H. Lyles, J. Bostwick, D. R. Murray, C. A. Staley, and W. C. Wood
Local Recurrence After Skin-Sparing Mastectomy: Tumor Biology or Surgical Conservatism?
Ann. Surg. Oncol., March 1, 2003; 10(2): 108 - 112.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
R. D. Foster, L. J. Esserman, J. P. Anthony, E.-s. S. Hwang, and H. Do
Skin-Sparing Mastectomy and Immediate Breast Reconstruction: A Prospective Cohort Study for the Treatment of Advanced Stages of Breast Carcinoma
Ann. Surg. Oncol., June 1, 2002; 9(5): 462 - 466.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
R. M. Simmons, M. Brennan, P. Christos, V. King, and M. Osborne
Analysis of Nipple/Areolar Involvement With Mastectomy: Can the Areola Be Preserved?
Ann. Surg. Oncol., March 1, 2002; 9(2): 165 - 168.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
B. L. Stradling, M. Ahn, J. Angelats, and S. G. A. Gabram
Skin-Sparing Mastectomy With Sentinel Lymph Node Dissection: Less Is More
Arch Surg, September 1, 2001; 136(9): 1069 - 1075.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the Society of Surgical Oncology.